Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 3Trigger Finger Disorder 1Stomach Neoplasms 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Nose Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Kidney Neoplasms 1Ganglion Cysts 1Esthesioneuroblastoma, Olfactory 1Dupuytren Contracture 1De Quervain Disease 1Colorectal Neoplasms 1Cognitive Dysfunction 1Carpal Tunnel Syndrome 1Cachexia 1Biliary Tract Neoplasms 1

Interventions

Filgrastim 3Etoposide 3Cisplatin 3Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2sargramostim 1etoposide phosphate 1enasidenib 1apatinib 1aldesleukin 1Tomography, X-Ray Computed 1Thiotepa 1Ritonavir 1Radionuclide Imaging 1Positron-Emission Tomography 1Paclitaxel 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Indinavir 1Ifosfamide 1Ibuprofen 1Gemcitabine 1Endoscopic Mucosal Resection 1Electrocardiography 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Carmustine 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Esthesioneuroblastoma, Olfactory × Ibuprofen × Clear all
NCT05012098 2025-08-08

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 14 charts
CNS

Nose Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡